“…A large number of studies have established a critical role for EPAC1 in the invasion and metastasis of several cancers including melanoma (45)(46)(47)(48)(49)(50)333), prostate cancer (42,362,688,711,713), ovarian cancer (62,855), pancreatic cancer (13,17,123,636,1095), cervical cancer (589), fibrosarcoma (399), and lung cancer (463,614). While the majority of reports suggest that EPAC1 activation promotes cancer cell migration and metastasis, few studies, using an EPAC-selective agonist 007, suggest that activation of EPAC1 inhibits cancer cell migration (62,362).…”